AGO-OVAR 2.29

Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

Trial Number
NCT03353831
Contact Person
Status
Completed
Disease Site
Recurrent Ovarian
Lead Cooperative Group
Participating Groups
AGO-AUST
BGOG
GEICO
GINECO
NSGO-CTU
SAKK
GCIG Number